Vivifrail Program on the Degree of Debilitation in Hospitalized Patients After Venous Hemolysis in Acute Ischemic Stroke
Launched by AFFILIATED HOSPITAL OF NANTONG UNIVERSITY · Apr 25, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Vivifrail Program is a clinical trial that is studying how physical exercise can help older adults who have been hospitalized due to an ischemic stroke, a type of stroke caused by a blockage in the blood vessels supplying the brain. The goal is to see if exercise can reduce debilitating symptoms and improve overall function in these patients. This is important because staying active can not only help with physical abilities but also improve thinking skills in older adults who may be facing challenges such as dementia or cognitive decline.
To participate in this trial, you need to be at least 65 years old and have been diagnosed with an ischemic stroke. You should also have a specific level of physical strength and be willing to actively engage in the program. However, if you have recently had a fracture, severe cognitive issues, or other serious health problems that prevent you from exercising, you may not be eligible. If you join the study, you can expect to take part in an exercise program designed to help you regain strength and improve your quality of life after your stroke.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Over 65 years of age;
- • 2. Hospitalized patients diagnosed with ischemic stroke;
- • 3. barthel index ≥60;
- • 4. Muscle strength of both upper and lower limbs is above grade 3;
- • 5. The pre-frailty and frailty state of the modified 5 Frailty Index (mFI-5) standard;
- • 6. Patients willing to cooperate and sign informed consent
- Exclusion Criteria:
- • 1. fracture (within three months),
- • 2. severe cognitive impairment, or severe dementia;
- • 3. unable or unwilling to cooperate, any other unstable medical condition, or conditions that would prevent physical activity
About Affiliated Hospital Of Nantong University
The Affiliated Hospital of Nantong University is a leading medical institution dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the hospital is committed to enhancing patient care by conducting rigorous studies that align with ethical standards and regulatory requirements. With a strong emphasis on collaboration among multidisciplinary teams, the hospital leverages its state-of-the-art facilities and expert staff to foster groundbreaking research initiatives aimed at improving treatment outcomes and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nantong, Jiangsu, China
Patients applied
Trial Officials
xuemei zhang, master
Study Chair
Affiliated Hospital of Nantong University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported